Remove 2023 Remove Communication Remove Packaging
article thumbnail

Independent Pharmacists’ Unique Role During Disaster Management Efforts

Drug Topics

1 Natural disasters have reached unprecedented levels in the past 5 years, with 2020, 2023, and 2024 being the most destructive and costly since before 1980. Aside from properly preparing medications during a disaster, Phillips mentioned the importance of establishing communication with patients.

article thumbnail

How ready are you? Preparing for the impact of EU GMP Annex 1 on primary packaging

European Pharmaceutical Review

While it officially applies to the manufacture of sterile medicinal products in the European Union, the revised EU Good Manufacturing Practice (GMP) Annex 1 effectively reset the benchmark for quality standards across the globe on 25 August 2023. Register your details to read more The post How ready are you?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA issues draft guidance on alternative tools for facility assessments

European Pharmaceutical Review

Assessing drug manufacturing facilities using alternative tools The FDA stated in the guidance that all manufacturing, packaging, and control sites for drug substance and drug product facilities are expected to be ready for inspection at the time of application submission.

FDA 105
article thumbnail

Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers

European Pharmaceutical Review

These chemicals are everywhere and have been used in many ways over the decades, bringing a range of benefits from water- and stain-resistant coatings and firefighting foams to nail polish and food packaging. However, the world is now learning they are also persistent pollutants that contaminate our soil, water and air.

article thumbnail

Commercial clinical trial investment announced by Government to ease NHS pressure

Hospital Pharmacy Europe

This much-anticipated independent review, commissioned by the Government in February 2023, offers 27 recommendations, addressing eight problem statements, on how the Government should work to resolve key challenges in conducting commercial clinical trials in the short and longer term.

article thumbnail

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

PharmTech

The decision was communicated through a Department of Health and Human Services (HHS) press release. Kennedy Jr.

article thumbnail

Harbour BioMed partners Otsuka on new T-cell therapy

Pharmaceutical Technology

In August 2023, the therapy received investigational new drug clearance from China’s National Medical Products Administration to start a Phase I cancer trial. We may still continue to send you service-related and other non-promotional communications. Sign up for our daily news round-up!